Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Nonalcoholic fatty liver disease in CLOCK mutant mice
Xiaoyue Pan, … , Joyce Queiroz, M. Mahmood Hussain
Xiaoyue Pan, … , Joyce Queiroz, M. Mahmood Hussain
Published May 12, 2020
Citation Information: J Clin Invest. 2020;130(8):4282-4300. https://doi.org/10.1172/JCI132765.
View: Text | PDF
Research Article Hepatology Metabolism

Nonalcoholic fatty liver disease in CLOCK mutant mice

  • Text
  • PDF
Abstract

Nonalcoholic fatty liver disease (NAFLD) is becoming a major health issue as obesity increases around the world. We studied the effect of a circadian locomotor output cycles kaput (CLOCK) mutant (ClkΔ19/Δ19) protein on hepatic lipid metabolism in C57BL/6 Clkwt/wt and apolipoprotein E–deficient (Apoe−/−) mice. Both ClkΔ19/Δ19 and ClkΔ19/Δ19 Apoe−/− mice developed a full spectrum of liver diseases (steatosis, steatohepatitis, cirrhosis, and hepatocellular carcinoma) recognized in human NAFLD when challenged with a Western diet, lipopolysaccharide, or CoCl2. We identified induction of CD36 and hypoxia-inducible factor 1α (HIF1α) proteins as contributing factors for NAFLD. Mechanistic studies showed that WT CLOCK protein interacted with the E-box enhancer elements in the promoters of the proline hydroxylase domain (PHD) proteins to increase expression. In ClkΔ19/Δ19 mice, PHD levels were low, and HIF1α protein levels were increased. When its levels were high, HIF1α interacted with the Cd36 promoter to augment expression and enhance fatty acid uptake. Thus, these studies establish a regulatory link among circadian rhythms, hypoxia response, fatty acid uptake, and NAFLD. The mouse models described here may be useful for further mechanistic studies in the progression of liver diseases and in the discovery of drugs for the treatment of these disorders.

Authors

Xiaoyue Pan, Joyce Queiroz, M. Mahmood Hussain

×

Figure 2

Hepatosteatosis in ClkΔ19/Δ19 mice challenged with CoCl2.

Options: View larger image (or click on image) Download as PowerPoint
Hepatosteatosis in ClkΔ19/Δ19 mice challenged with CoCl2.
Male (8-month-...
Male (8-month-old) ClkΔ19/Δ19 and Clkwt/wt mice fed a Western diet for 2 months were injected i.p. 3 times with 30 mg/kg CoCl2 on alternate days, and continued on the same diet ad libitum for 2 months. Mice were used for tissue analysis (n = 6 per group) or to study hepatic uptake of [3H]OA (n = 5–6 per group). (A–E) Livers were used to measure mRNA levels. Mean ± SD; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, multiple t tests. (F) Frozen liver sections were used for Oil Red O, H&E, and anti-macrophage (anti-CD68) staining. Pictures are representative of 3 experiments. (G and H) Livers were used to measure triglyceride (G) and TBARS (H). Mean ± SD; ****P < 0.0001, Welch’s 2-tailed t test. (I) Plasma ALT and β-HB levels in ClkΔ19/Δ19 mice injected with CoCl2. Mean ± SD; **P < 0.01, ****P < 0.0001, Welch’s 2-tailed t test. (J) ClkΔ19/Δ19 and Clkwt/wt mice were injected with CoCl2. Two weeks later, mice were injected i.p. with [3H]OA. After 2 hours, livers were collected, and radioactivity was measured. Mean ± SD; ****P < 0.0001, Welch’s 2-tailed t test. (K) Liver slices from 10-month-old ClkΔ19/Δ19 and Clkwt/wt mice treated with CoCl2 were incubated with [3H]OA (1 μCi/mL) for 1 hour, washed, and used to measure protein and radioactivity. Mean ± SD; *P < 0.05, ****P < 0.0001, 2-way ANOVA, Šidák’s multiple-comparisons test. (L) Liver slices from 10-month-old ClkΔ19/Δ19 and Clkwt/wt mice treated with or without CoCl2 were incubated with [14C]palmitic acid (PA) (1 μCi/mL) for 2 hours. 14CO2 adsorbed to paper and acid-precipitated intermediates were counted. Mean ± SD; *P < 0.05, **P < 0.01, 2-way ANOVA, Šidák’s multiple-comparisons test. (M) Primary hepatocytes from ClkΔ19/Δ19 and Clkwt/wt mice were treated with CoCl2 (250 μM) for 12 hours, incubated with 0.5 μCi/mL of [3H]OA for 1 hour, washed, and counted. Mean ± SD; *P < 0.05, **P < 0.01, ****P < 0.0001, 2-way ANOVA, Šidák’s multiple-comparisons test. (N) Primary hepatocytes from ClkΔ19/Δ19 and Clkwt/wt mice were treated with DMOG (500 μM) for 8 hours, incubated for 1 hour with 0.5 μCi/mL [3H]OA, and washed, and radioactivity was determined to measure uptake or hepatocytes were incubated with [14C]PA for 1 hour to study fatty acid oxidation. Mean ± SD; *P < 0.05, ***P < 0.001, 2-way ANOVA, Šidák’s multiple-comparisons test. (O) WT hepatocytes were transduced in triplicate with adenoviruses expressing shCLOCK, shHIF1α, shCD36, or shCTRL. After 60 hours, cells were treated with CoCl2 for 12 hours and fatty acid uptake was measured. Mean ± SD; ***P < 0.001, 2-way ANOVA, Šidák’s multiple-comparisons test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts